drugset / Trial / NCT00002180

A Study of PMPA in HIV-Infected Patients

NCT00002180

Phase 1 Completed Gilead Sciences
Double-blindTreatment

Summary

The purpose of this study is to see if it is safe and effective to give PMPA to HIV-infected patients. This study also examines how the body handles PMPA.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tenofovir Small molecule